Food Design for Improved Day-long Glycaemic Regulation

Poor Glycemic Control Clinical Trial

Official title:

The Effect on Glucose Tolerance at a Second Meal Provided After Breakfast Meal Giving Late Increment in Postprandial Glycaemia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02876029
• Other study ID #: AFC-GPSecMeal
• Status: Completed
• Phase: N/A
• First received: August 18, 2016
• Last updated: August 26, 2016
• Start date: September 2014
• Est. completion date: March 2015

Study information

• Verified date: August 2016
• Source: Lund University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Sweden: Regional Ethical Review Board
• Study type: Interventional

Clinical Trial Summary

The study focus is on the possible improvement in glucose tolerance at a second standardized meal that can be achieved when preceded by a test meal with a low GI and a high GP.

Description:

A study in healthy subjects using spaghetti as the test breakfast and a white wheat bread as the reference. Glycaemia, insulinaemia, NEFA, TG and subjective appetite are studied up to the time of the lunch meal that is served 4h after breakfast. After lunch the blood sampling continues for 2 hours.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: March 2015
• Est. primary completion date: December 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• BMI 19-25

Exclusion Criteria:

• Smoker, Diabetes, Gluten intolerance, vegetarian

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention

Related Conditions & MeSH terms

• Poor Glycemic Control

Intervention

Other:
• Reference
the reference product used
• Test product
The test Product used

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Lund University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Glucose		0-6 h	No
Secondary	Non-esterified fatty acids (NEFA)		0-6 h	No
Secondary	Triglycerides (TG)		0-6 h	No
Secondary	Appetite rating (Visual Analogue Scale)		0-6 h	No
Secondary	Insulin		0-6 h	No